Concepedia

Matthew Tanner

MT

Statistics

Publications

5

Citations

236

H-Index

5

Active since

2015

Affiliations

University of Rochester Medical Center(Current)

Biogen (United States)

University of Florida

Matthew Tanner is an author at University of Rochester Medical Center specializing in muscular dystrophy, molecular biology, and gene expression.

ORCID

Publications per year

2015–2025

5

Publications

5

Actinomycin D Specifically Reduces Expanded CUG Repeat RNA in Myotonic Dystrophy Models

Ruth B. Siboni, Masayuki Nakamori, Stacey D. Wagner et al. · Cell Reports · 2015 · 87 citations · Full text

, , +13

Antisense oligonucleotide targeting DMPK in patients with myotonic dystrophy type 1: a multicentre, randomised, dose-escalation, placebo-controlled, phase 1/2a trial

Charles A. Thornton, Richard T. Moxley, Katy Eichinger et al. · The Lancet Neurology · 2023 · 59 citations

, , +3

Targeted splice sequencing reveals RNA toxicity and therapeutic response in myotonic dystrophy

Matthew Tanner, Zhenzhi Tang, Charles A. Thornton · Nucleic Acids Research · 2021 · 44 citations · Full text

, , +15

FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models

Timothy Weeden, Tyler Picariello, Brendan Quinn et al. · Communications Medicine · 2025 · 24 citations · Full text

, , +15

CDK12 inhibition reduces abnormalities in cells from patients with myotonic dystrophy and in a mouse model

Ami Ketley, Marzena Wojciechowska, Sonja Ghidelli‐Disse et al. · Science Translational Medicine · 2020 · 22 citations · Full text

, , +8

1–5 of 5